PRECISION BRAIN TUMOR THERAPY BY AAV-MEDIATED ONCOGENE EDITING

被引：0

作者：

von Soosten, Laura ^{[1
,2
,3
]}

Haar, Janina ^{[4
]}

Frehtman, Veronika ^{[5
]}

Holderbach, Stefan ^{[4
,6
]}

zu Belzen, Julius Upmeier ^{[6
,7
,8
]}

Jendrusch, Michael ^{[6
,9
]}

Okonechnikov, Konstantin ^{[2
,10
,11
]}

Pfister, Stefan M. ^{[2
,10
,11
,12
]}

Grimm, Dirk ^{[4
,13
,14
]}

Leuchs, Barbara ^{[5
]}

Jones, David ^{[1
,2
]}

Kutscher, Lena M. ^{[2
,15
]}

Zuckermann, Marc ^{[1
,2
]}

机构：

[1] Hopp Childrens Canc Ctr Heidelberg KiTZ, Div Pediat Glioma Res, Heidelberg, Germany

[2] German Canc Res Ctr, Heidelberg, Germany

[3] Heidelberg Univ, Fac Biosci, Heidelberg, Germany

[4] Heidelberg Univ, Fac Med, Dept Infect Dis Virol, BioQuant, Heidelberg, Germany

[5] German Canc Res Ctr, Tumor Virol, Heidelberg, Germany

[6] Heidelberg Univ, Synthet Biol Grp, BioQuant Ctr, Heidelberg, Germany

[7] Berlin Inst Hlth BIH, Digital Hlth Ctr, Berlin, Germany

[8] Charite, Berlin, Germany

[9] European Mol Biol Lab EMBL, Heidelberg, Germany

[10] Hopp Childrens Canc Ctr Heidelberg KiTZ, Div Pediat Neurooncol, Heidelberg, Germany

[11] German Canc Consortium DKTK, Heidelberg, Germany

[12] Heidelberg Univ Hosp, Dept Pediat Oncol Hematol Immunol & Pulmonol, Heidelberg, Germany

[13] German Ctr Infect Res DZIF, Heidelberg, Germany

[14] German Ctr Cardiovasc Res DZHK, Heidelberg, Germany

[15] Hopp Childrens Canc Ctr Heidelberg KiTZ, JRG Dev Origins Pediat Canc, Heidelberg, Germany

来源：

NEURO-ONCOLOGY | 2022年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

THER-01

引用

页码：185 / 186

页数：2

共 50 条

[1] AAV-mediated protein trans-splicing and genome editing for therapy of Haemophilia A
Lyubenova, H.
Minopoli, R.
Llado, M.
Nusco, E.
Auricchio, A.
HUMAN GENE THERAPY, 2019, 30 (11) : A83 - A83
[2] Efficient AAV-mediated prime editing in mouse retina
Liu, Qin
Butcher, Rossano
Davis, Jessie
Collin, Caitlin
Liu, David
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
[3] AAV-mediated gene editing lights up the lung
Yan, Ziying
Lynch, Thomas J.
Engelhardt, John F.
MOLECULAR THERAPY, 2022, 30 (01) : 7 - 9
[4] AAV-Mediated Gene Therapy for Atherosclerosis
Michael Lehrke
Corinna Lebherz
Current Atherosclerosis Reports, 2014, 16
[5] AAV-mediated gene therapy for sialidosis
van de Vlekkert, Diantha
Hu, Huimin
Weesner, Jason A.
Fremuth, Leigh E.
Brown, Scott A.
Lu, Meifen
Gomero, Elida
Campos, Yvan
Sheppard, Heather
d'Azzo, Alessandra
MOLECULAR THERAPY, 2024, 32 (07) : 2094 - 2112
[6] AAV-mediated gene therapy for fALS
Cappella, M.
Cohen-Tannoudji, M.
Marais, T.
Astord, S.
Besse, A.
Giroux, B.
Barkats, M.
Biferi, M. G.
HUMAN GENE THERAPY, 2018, 29 (12) : A109 - A109
[7] AAV-mediated gene therapy for hemophilia
Couto, LB
Pierce, GF
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (05) : 517 - 523
[8] AAV-Mediated Gene Therapy for Atherosclerosis
Lehrke, Michael
Lebherz, Corinna
CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (09)
[9] AAV-mediated gene therapies by miniature gene editing tools
Kong, Xiangfeng
Li, Tong
Yang, Hui
SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (12) : 2540 - 2553
[10] AAV-mediated in vivo genome editing in vascular endothelial cells
Wu, Wenyi
Yang, Yanhui
Yao, Fei
Dong, Lijun
Xia, Xiaobo
Zhang, Shaochong
Lei, Hetian
METHODS, 2021, 194 : 12 - 17

← 1 2 3 4 5 →